Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Subject Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Program
    • Feedback
    • Reprints
    • Impact Factor
  • ASN Kidney News
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Subject Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Program
    • Feedback
    • Reprints
    • Impact Factor
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
Pathophysiology of Renal Disease and Progression
You have accessRestricted Access

Connective Tissue Growth Factor Plays an Important Role in Advanced Glycation End Product–Induced Tubular Epithelial-to-Mesenchymal Transition: Implications for Diabetic Renal Disease

Wendy C. Burns, Stephen M. Twigg, Josephine M. Forbes, Josefa Pete, Christos Tikellis, Vicki Thallas-Bonke, Merlin C. Thomas, Mark E. Cooper and Phillip Kantharidis
JASN September 2006, 17 (9) 2484-2494; DOI: https://doi.org/10.1681/ASN.2006050525
Wendy C. Burns
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen M. Twigg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Josephine M. Forbes
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Josefa Pete
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christos Tikellis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vicki Thallas-Bonke
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Merlin C. Thomas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark E. Cooper
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Phillip Kantharidis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    TGF-β1 (10 ng/ml) and advanced glycation end product (AGE)-modified BSA (AGE-BSA; 40 μM) induce epithelial-to-mesenchymal transition (EMT) in NRK-52E cells as determined by cellular morphology after 6 d of exposure (left), de novo expression of α-smooth muscle actin (αSMA; middle), and reduction of E-cadherin expression (right). BSA-treated (40 μM) cells show an intermediate phenotype. α-SMA and E-cadherin expression is shown in green. Cells were counterstained with propidium iodide (red) to demonstrate the nuclei.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    TGF-β1 (10 ng/ml), AGE-BSA, and BSA (40 μM) induce the gene and protein expression of α-SMA in NRK-52E cells, as shown by real-time reverse transcription–PCR (RT-PCR; A) and a representative Western blot (B). Each bar represents the mean ± SEM of six samples per group. *P < 0.01 versus control; #P < 0.05 versus BSA.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    TGF-β1, AGE-BSA, and BSA reduce the gene and protein expression of E-cadherin in NRK-52E cells, as demonstrated by real-time RT-PCR (A) and a representative Western blot (B). Each bar represents the mean ± SEM of six (mRNA) or three (protein) samples per group. *P < 0.05 versus control; #P < 0.01 versus BSA.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    TGF-β1 and AGE-BSA induce the gene and protein expression of connective tissue growth factor (CTGF) in NRK-52E cells, as demonstrated by real-time RT-PCR (A) and representative Western blot analysis of whole-cell lysates (B). (C) Western blot of control and TGF-β1 samples demonstrating expression of CTGF protein. To enable the quantification of CTGF, loading in B was adjusted for TGF-β1 samples to prevent saturation of signal (lanes 4 through 6). Even loading of the control and TGF-β1 samples is shown in C. Each bar represents the mean ± SEM of six (mRNA) or three (protein) samples per group. *P < 0.01 versus control; #P < 0.01 versus BSA.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    TGF-β1, AGE-BSA, and BSA induce the gene expression of the matrix molecules collagen IV and fibronectin in NRK-52E cells, as demonstrated by real-time RT-PCR. Each bar represents the mean ± SEM of three to six samples per group *P < 0.01 versus control; #P < 0.05 versus BSA.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    NRK-52E cells that were stimulated with CTGF sense adenovirus for 3 (A) or 6 d (B) undergo EMT, as demonstrated by cellular morphology, de novo expression of α-SMA, and reduced expression of E-cadherin at membrane junctions, with relocalization to the perinuclear region (arrow).

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7.

    NRK-52E cells that were infected with CTGF sense adenovirus for 3 or 6 d alter the gene expression of the EMT markers α-SMA vimentin, and E-cadherin (A) and the ECM molecules collagen IV and fibronectin (C) in NRK-52E cells, as demonstrated by real-time RT-PCR. (B) NRK-52E cells that were infected with CTGF sense adenovirus for 3 d show decreased expression of E-cadherin protein as assessed by Western blot. Each bar represents the mean ± SEM of six samples per group. *P < 0.01 versus vector control.

  • Figure 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 8.

    EMT in NRK-52E cells associated with BSA and AGE-BSA (A) or control and TGF-β1 treatments (B) was investigated after transfection with CTGF-286; this was assessed by light microscopy and confocal microscopy of cells immunostained for α-SMA, vimentin, and E-cadherin. α-SMA, vimentin, and E-cadherin are seen in green. Cell nuclei were counterstained with propidium iodide (red). Magnifications: light microscopy ×200; confocal ×440.

  • Figure 9.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 9.

    Renal expression of TGF-β1, CTGF, α-SMA, and collagen IV mRNA, as assessed by in situ hybridization. Study groups are control, diabetic for 32 wk, and diabetes + alagebrium treatment (Diab+ALT) from 16 to 32 wk.

  • Figure 10.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 10.

    (A) Co-localization of CTGF and α-SMA in the diabetic tubule as assessed by in situ hybridization in serial renal sections. Images are shown in light field (top) or dark field (bottom). (B) E-cadherin protein expression, as assessed by immunohistochemistry. Study groups are control, diabetes for 32 wk, and diabetes+ALT from 16 to 32 wk.

Tables

  • Figures
    • View popup
    Table 1.

    Probe and primer sequences used for real-time RT-PCR analysisa

    Probe/PrimerSequence
    Collagen IV
        forward primer 5′-3′GGCGGTACACAGTCAGACCAT
        probeFAM-CCGCAGTGCCCTAACGGTTGGTC-MGB
        reverse primer 5′-3′GGAATAGCCGATCCACAGTGA
    CTGF
        forward primer 5′-3′TGGCCCTGACCCAACTATGA
        probeFAM-ACTGCCTGGTCCAGAC-MGB
        reverse primer 5′-3′CTTAGAACAGGCGCTCCACTCT
    E-cadherin
        forward primer 5′-3′AACGAGGGCATTCTGAAAACA
        probeFAM-TGCTTGGCCTCAAAATCCAAGCCCT-MGB
        reverse primer 5′-3′CACTGTCACGTGCAGAATGTACTG
    Fibronectin
        forward primer 5′-3′CATGGCTTTAGGCGAACCA
        probeFAM-CCCCGTCAGGCTTA-MGB
        reverse primer 5′-3′CATCTACATTCGGCAGGTATGG
    α-SMA
        forward primer 5′-3′GACCCTGAAGTATCCGATAGAACA
        probeFAM-TGCCAGATCTTTTCC-MGB
        reverse primer 5′-3′CACGCGAAGCTCGTTATAGAAG
    Vimentin
        forward primer 5′-3′CCATCAACACCGAGTTCAAGAA
        probeFAM-CCGCACCAACGAGA -MGB
        reverse primer 5′-3′GGCGAAGCGGTCATTCAG
    • ↵a CTGF, connective tissue growth factor; RT-PCR, real time reverse transcription–PCR; α -SMA, α -smooth muscle actin.

PreviousNext
Back to top

In this issue

Journal of the American Society of Nephrology: 17 (9)
Journal of the American Society of Nephrology
Vol. 17, Issue 9
September 2006
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
Connective Tissue Growth Factor Plays an Important Role in Advanced Glycation End Product–Induced Tubular Epithelial-to-Mesenchymal Transition: Implications for Diabetic Renal Disease
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Connective Tissue Growth Factor Plays an Important Role in Advanced Glycation End Product–Induced Tubular Epithelial-to-Mesenchymal Transition: Implications for Diabetic Renal Disease
Wendy C. Burns, Stephen M. Twigg, Josephine M. Forbes, Josefa Pete, Christos Tikellis, Vicki Thallas-Bonke, Merlin C. Thomas, Mark E. Cooper, Phillip Kantharidis
JASN Sep 2006, 17 (9) 2484-2494; DOI: 10.1681/ASN.2006050525

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Connective Tissue Growth Factor Plays an Important Role in Advanced Glycation End Product–Induced Tubular Epithelial-to-Mesenchymal Transition: Implications for Diabetic Renal Disease
Wendy C. Burns, Stephen M. Twigg, Josephine M. Forbes, Josefa Pete, Christos Tikellis, Vicki Thallas-Bonke, Merlin C. Thomas, Mark E. Cooper, Phillip Kantharidis
JASN Sep 2006, 17 (9) 2484-2494; DOI: 10.1681/ASN.2006050525
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

  • Slowly Progressive, Angiotensin II–Independent Glomerulosclerosis in Human (Pro)renin Receptor–Transgenic Rats
  • Combination Therapy with an Angiotensin-Converting Enzyme Inhibitor and a Vitamin D Analog Suppresses the Progression of Renal Insufficiency in Uremic Rats
  • Evidence for the Role of Reactive Nitrogen Species in Polymicrobial Sepsis-Induced Renal Peritubular Capillary Dysfunction and Tubular Injury
Show more Pathophysiology of Renal Disease and Progression

Cited By...

  • Autophagy Inhibits the Accumulation of Advanced Glycation End Products by Promoting Lysosomal Biogenesis and Function in the Kidney Proximal Tubules
  • miR-483 Targeting of CTGF Suppresses Endothelial-to-Mesenchymal Transition: Therapeutic Implications in Kawasaki Disease
  • Arg tyrosine kinase modulates TGF-{beta}1 production in human renal tubular cells under high-glucose conditions
  • Genetic Deletion of Cell Division Autoantigen 1 Retards Diabetes-Associated Renal Injury
  • Role of the TGF-{beta}/BMP-7/Smad pathways in renal diseases
  • CCN2/CTGF increases expression of miR-302 microRNAs, which target the TGF{beta} type II receptor with implications for nephropathic cell phenotypes
  • Suppression of microRNA-29 Expression by TGF-{beta}1 Promotes Collagen Expression and Renal Fibrosis
  • Heparanase and Syndecan-1 Interplay Orchestrates Fibroblast Growth Factor-2-induced Epithelial-Mesenchymal Transition in Renal Tubular Cells
  • The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma
  • Effects of Antiproteinuric Intervention on Elevated Connective Tissue Growth Factor (CTGF/CCN-2) Plasma and Urine Levels in Nondiabetic Nephropathy
  • Angiotensin II as a Morphogenic Cytokine Stimulating Renal Fibrogenesis
  • miR-200a Prevents Renal Fibrogenesis Through Repression of TGF-{beta}2 Expression
  • Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria
  • E-Cadherin Expression Is Regulated by miR-192/215 by a Mechanism That Is Independent of the Profibrotic Effects of Transforming Growth Factor-{beta}
  • Vitamin D Receptor Attenuates Renal Fibrosis by Suppressing the Renin-Angiotensin System
  • Advanced Glycation End-Products Induce Tubular CTGF via TGF-{beta}-Independent Smad3 Signaling
  • New Insights into Epithelial-Mesenchymal Transition in Kidney Fibrosis
  • Angiotensin II Induces Connective Tissue Growth Factor and Collagen I Expression via Transforming Growth Factor-{beta}-Dependent and -Independent Smad Pathways: The Role of Smad3
  • CTGF Promotes Inflammatory Cell Infiltration of the Renal Interstitium by Activating NF-{kappa}B
  • TISSUE FACTOR AND FACTOR V INVOLVEMENT IN RAT PERITONEAL FIBROSIS
  • RGC-32 Mediates Transforming Growth Factor-{beta}-induced Epithelial-Mesenchymal Transition in Human Renal Proximal Tubular Cells
  • CTGF Inhibits BMP-7 Signaling in Diabetic Nephropathy
  • Plasma Connective Tissue Growth Factor Is an Independent Predictor of End-Stage Renal Disease and Mortality in Type 1 Diabetic Nephropathy
  • Google Scholar

Similar Articles

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire